Guest guest Posted December 6, 2007 Report Share Posted December 6, 2007 FDA Evaluating Adverse Reports for Stop-Smoking Drug The maker of Chantix (varenicline), a prescription medicine to help adults stop smoking, has submitted reports to FDA describing suicidal thoughts in people taking the drug. FDA is working on an analysis of available information and will communicate conclusions and recommendations when complete. Meanwhile, the agency recommends that health care providers monitor patients taking Chantix for behavior and mood changes. Patients taking Chantix should contact their doctors if they experience behavior or mood changes. http://www.fda.gov/bbs/topics/NEWS/2007/NEW01749.html Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.